Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L K Hummers

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Rheumatology (Oxford, England)|September 17, 2008
Biomarkers of vascular disease in sclerodermaL K Hummers
Annals of the Rheumatic Diseases|August 14, 2009
The "tank top sign": a unique pattern of skin fibrosis seen in pansclerotic morpheaN S Sherber, F Boin, L K Hummers, et al.
Annals of the Rheumatic Diseases|November 3, 2007
High-dose cyclophosphamide without stem cell rescue in sclerodermaC V Tehlirian, L K Hummers, B White, et al.
Gut|March 11, 2006
A case-control study of the pathology of oesophageal disease in systemic sclerosis (scleroderma)C G P Roberts, L K Hummers, W J Ravich, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|February 18, 2006
Abnormal exhaled ethane concentrations in sclerodermaK A Cope, S F Solga, L K Hummers, et al.
Neurology|January 14, 2004
Recurrent transverse myelitis associates with anti-Ro (SSA) autoantibodiesL K Hummers, C Krishnan, L Casciola-Rosen, et al.
Annals of the Rheumatic Diseases|January 18, 2006
Distinct recognition of antibodies to centromere proteins in primary Sjogren's syndrome compared with limited sclerodermaA C Gelber, S R Pillemer, B J Baum, et al.
Clinical Rheumatology|January 18, 2021
PM-Scl and Th/To in systemic sclerosis: a comparison of different autoantibody assaysC A Mecoli, L Gutierrez-Alamillo, Q Yang, et al.
The European Respiratory Journal|February 12, 2011
Outcomes of hospitalisation for right heart failure in pulmonary arterial hypertensionA Campo, S C Mathai, J Le Pavec, et al.
Clinical and Experimental Rheumatology|November 6, 2014
Pulmonary hypertension and interstitial lung disease within PHAROS: impact of extent of fibrosis and pulmonary physiology on cardiac haemodynamic parametersA Fischer, J J Swigris, M B Bolster, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Rheumatology (Oxford, England)|September 17, 2008
Biomarkers of vascular disease in sclerodermaL K Hummers
Annals of the Rheumatic Diseases|August 14, 2009
The "tank top sign": a unique pattern of skin fibrosis seen in pansclerotic morpheaN S Sherber, F Boin, L K Hummers, et al.
Annals of the Rheumatic Diseases|November 3, 2007
High-dose cyclophosphamide without stem cell rescue in sclerodermaC V Tehlirian, L K Hummers, B White, et al.
Gut|March 11, 2006
A case-control study of the pathology of oesophageal disease in systemic sclerosis (scleroderma)C G P Roberts, L K Hummers, W J Ravich, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|February 18, 2006
Abnormal exhaled ethane concentrations in sclerodermaK A Cope, S F Solga, L K Hummers, et al.
Neurology|January 14, 2004
Recurrent transverse myelitis associates with anti-Ro (SSA) autoantibodiesL K Hummers, C Krishnan, L Casciola-Rosen, et al.
Annals of the Rheumatic Diseases|January 18, 2006
Distinct recognition of antibodies to centromere proteins in primary Sjogren's syndrome compared with limited sclerodermaA C Gelber, S R Pillemer, B J Baum, et al.
Clinical Rheumatology|January 18, 2021
PM-Scl and Th/To in systemic sclerosis: a comparison of different autoantibody assaysC A Mecoli, L Gutierrez-Alamillo, Q Yang, et al.
The European Respiratory Journal|February 12, 2011
Outcomes of hospitalisation for right heart failure in pulmonary arterial hypertensionA Campo, S C Mathai, J Le Pavec, et al.
Clinical and Experimental Rheumatology|November 6, 2014
Pulmonary hypertension and interstitial lung disease within PHAROS: impact of extent of fibrosis and pulmonary physiology on cardiac haemodynamic parametersA Fischer, J J Swigris, M B Bolster, et al.
Pageof 2